374633-29-1 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Bromo-6-cyanoindole is used as a key building block for the synthesis of indole-based compounds, which are essential in the development of pharmaceuticals. Its unique structure allows for the creation of a wide range of therapeutic agents.
Used in Agrochemical Production:
In the agrochemical industry, 4-Bromo-6-cyanoindole is used as a precursor in the synthesis of various agrochemicals, contributing to the development of effective pest control solutions and crop protection products.
Used in Research and Development:
4-Bromo-6-cyanoindole is utilized in research and development for new drug discovery, particularly in the area of anti-cancer agents. Its potential in this field is being explored through various scientific studies and experiments.
Used in Organic Synthesis:
4-BROMO-6-CYANOINDOLE is also used in organic synthesis for the production of a variety of organic compounds, which find applications in different industries, including the pharmaceutical sector.
Used in Cancer Treatment:
4-Bromo-6-cyanoindole is used as a potential anti-cancer agent, with ongoing research aimed at understanding its mechanism of action and effectiveness in treating various types of cancer. Its role in this application is significant due to the ongoing demand for new and effective cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 374633-29-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,4,6,3 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 374633-29:
(8*3)+(7*7)+(6*4)+(5*6)+(4*3)+(3*3)+(2*2)+(1*9)=161
161 % 10 = 1
So 374633-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H5BrN2/c10-8-3-6(5-11)4-9-7(8)1-2-12-9/h1-4,12H
374633-29-1Relevant articles and documents
CARBOXY SUBSTITUTED (HETERO) AROMATIC RING DERIVATIVES AND PREPARATION METHOD AND USES THEREOF
-
Page/Page column 93, (2017/03/21)
Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.